Notably, considerable evidence has confirmed the impact of CAFs on tumor progression and metastasis.[9] Thus, the present study, for the first time, constructed a CAF-derived prognostic signature to accurately predict patients with PCa at high risk of BCR in 5 independent PCa cohorts. The gene discussed is BCR; the disease is neoplasm.